Lv62
2290 积分 2023-11-07 加入
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
5小时前
已完结
Telitacicept, a novel humanized, recombinant TACI-Fc fusion protein, for the treatment of systemic lupus erythematosus
19天前
已完结
In vivo dendritic cell reprogramming for cancer immunotherapy
2个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
3个月前
已完结
T Cell Responses to Individualized Neoantigen Therapy mRNA-4157(V940)Alone or in Combination With Pembrolizumab in the Phase 1 KEYNOTE-603 Study
3个月前
已完结
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
4个月前
已完结
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors
4个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
4个月前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
4个月前
已完结
The BTLA–HVEM axis restricts CAR T cell efficacy in cancer
4个月前
已完结
皖公网安备34019202002308
